Laboratório de Lipides (LIM10), Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil.
Laboratório de Lipides (LIM10), Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil.
Clinics (Sao Paulo). 2022 Apr 6;77:100028. doi: 10.1016/j.clinsp.2022.100028. eCollection 2022.
Because the plasma campesterol/cholesterol ratio does not differ between groups that absorb different amounts of cholesterol, the authors investigated whether the plasma Phytosterols (PS) relate to the body's cholesterol synthesis rate measured as non-cholesterol sterol precursors (lathosterol).
The authors studied 38 non-obese volunteers (58±12 years; Low-Density Lipoprotein Cholesterol ‒ LDL-C ≥ 130 mg/dL) randomly assigned to consume 400 mL/day of soy milk (Control phase) or soy milk + PS (1.6 g/day) for four weeks in a double-blind, cross-over study. PS and lathosterol were measured in plasma by gas chromatography coupled to mass spectrophotometry.
PS treatment reduced plasma total cholesterol concentration (-5.5%, p < 0.001), LDL-C (-7.6%, p < 0.001), triglycerides (-13.6%, p < 0.0085), and apolipoprotein B (apo B) (-6.3%, p < 0.008), without changing high density lipoprotein cholesterol (HDL-C concentration), but plasma lathosterol, campesterol and sitosterol expressed per plasma cholesterol increased.
The lathosterol-to-cholesterol plasma ratio predicted the plasma cholesterol response to PS feeding. The highest plasma lathosterol concentration during the control phase was associated with a lack of response of plasma cholesterol during the PS treatment period. Consequently, cholesterol synthesis in non-responders to dietary PS being elevated in the control phase indicates these cases resist to further synthesis rise, whereas responders to dietary PS, having in the control phase synthesis values lower than non-responders, expand synthesis on alimentary PS. Responders absorb more PS than non-responders, likely resulting from responders delivering into the intestinal lumen less endogenous cholesterol than non-responders do, thus facilitating greater intestinal absorption of PS shown as increased plasma PS concentration.
由于血浆谷固醇/胆固醇比值在吸收不同量胆固醇的两组之间没有差异,作者研究了血浆植物甾醇(PS)是否与非胆固醇甾醇前体(羊毛甾醇)所测的机体胆固醇合成率有关。
作者研究了 38 名非肥胖志愿者(58±12 岁;低密度脂蛋白胆固醇 [LDL-C]≥130mg/dL),他们被随机分为两组,分别在双盲交叉研究中连续 4 周每天饮用 400ml 豆浆(对照组)或豆浆+PS(1.6g/d)。采用气相色谱-质谱联用法测量血浆中的 PS 和羊毛甾醇。
PS 治疗降低了血浆总胆固醇浓度(-5.5%,p<0.001)、LDL-C(-7.6%,p<0.001)、甘油三酯(-13.6%,p<0.0085)和载脂蛋白 B(apo B)(-6.3%,p<0.0085),而高密度脂蛋白胆固醇(HDL-C 浓度)没有变化,但血浆羊毛甾醇、谷固醇和菜油固醇与胆固醇的比值增加。
血浆羊毛甾醇/胆固醇比值预测了 PS 喂养对血浆胆固醇的反应。在对照组期间,血浆羊毛甾醇浓度最高与 PS 治疗期间血浆胆固醇反应缺乏有关。因此,非应答者在对照组中胆固醇合成升高,表明这些病例抵抗进一步合成升高,而对 PS 饮食有反应者在对照组中的合成值低于非应答者,因此在摄入 PS 后增加合成。对 PS 有反应者比无反应者吸收更多的 PS,可能是因为有反应者向肠腔输送的内源性胆固醇比无反应者少,从而促进 PS 的肠道吸收,表现为血浆 PS 浓度增加。